Skip to main content

Jennifer Ann Rothman, MD

Associate Professor of Pediatrics
Assistant Professor in Medicine
Campus mail: 385 Hanes House, Box 102382, Durham, NC 27710
Phone: (919) 684-3401
Email address: jennifer.rothman@duke.edu

Sickle Cell Disease
Bone Marrow Failure Syndromes
General Hematology

Education and Training

  • Pediatric Hem-Onc Fellowship, Pediatrics, Children's Hospital of Philadelphia, 2006 - 2009
  • Pediatric Residency, Pediatrics, Children's Hospital of Philadelphia, 2003 - 2006
  • M.D., University of Medicine and Dentistry of New Jersey, 2003

Publications

Hall, B. J., A. J. Reiter, B. R. Englum, J. A. Rothman, and H. E. Rice. “Long-term hematologic and clinical outcomes of splenectomy in children with hereditary spherocytosis and sickle cell disease.” Pediatric Blood and Cancer 67, no. 8 (August 1, 2020). https://doi.org/10.1002/pbc.28290.

Full Text

Rothman, Jennifer A. “Osteomyelitis in sickle cell disease: You know it when you see it?” Pediatr Blood Cancer, July 16, 2020, e28585. https://doi.org/10.1002/pbc.28585.

Full Text

Al-Samkari, Hanny, Eduard J. van Beers, D Holmes Morton, Wilma Barcellini, Stefan W. Eber, Bertil Glader, Hassan M. Yaish, et al. “Characterization of the severe phenotype of pyruvate kinase deficiency.” Am J Hematol, July 3, 2020. https://doi.org/10.1002/ajh.25926.

Full Text

Robles, Joanna, Marissa Just, Ashley Frazier, Karan Kumar, Andrew Yazman, Heather McLean, Jennifer Rothman, and Kristy Pahl. “VTE IN HOSPITALIZED PEDIATRIC PATIENTS: IMPLEMENTING A RISK ASSESSMENT TOOL.” In Pediatric Blood & Cancer, 67:S59–S59. WILEY, 2020.

Scholars@Duke

Al-Samkari, Hanny, Kathryn Addonizio, Bertil Glader, D Holmes Morton, Satheesh Chonat, Alexis A. Thompson, Kevin H. M. Kuo, et al. “The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.” Br J Haematol, May 28, 2020. https://doi.org/10.1111/bjh.16724.

Full Text

Rothman, Jennifer A., Jenny L. Stevens, Fabienne L. Gray, and Theodosia A. Kalfa. “How I approach hereditary hemolytic anemia and splenectomy.” Pediatr Blood Cancer, May 11, 2020, e28337. https://doi.org/10.1002/pbc.28337.

Full Text

Rogers, Zora R., Taizo A. Nakano, Timothy S. Olson, Alison A. Bertuch, Winfred Wang, Alfred Gillio, Thomas D. Coates, et al. “Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study.” Haematologica 104, no. 10 (October 2019): 1974–83. https://doi.org/10.3324/haematol.2018.206540.

Full Text

Grace, Rachael F., Kristin A. Shimano, Rukhmi Bhat, Cindy Neunert, James B. Bussel, Robert J. Klaassen, Michele P. Lambert, et al. “Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.” Am J Hematol 94, no. 7 (July 2019): 741–50. https://doi.org/10.1002/ajh.25479.

Full Text

Nannes, Caleb, Jennifer Rothman, Addison Gross, and Susan Kreissman. “IMPROVING NUTRITIONAL SUPPORT FOR PEDIATRIC HEMATOLOGY & ONCOLOGY PATIENTS.” In Pediatric Blood & Cancer, Vol. 66. WILEY, 2019.

Scholars@Duke

Gallagher, Patrick G., Yelena Maksimova, Kimberly Lezon-Geyda, Peter E. Newburger, Desiree Medeiros, Robin D. Hanson, Jennifer Rothman, et al. “Aberrant splicing contributes to severe α-spectrin-linked congenital hemolytic anemia.” J Clin Invest 129, no. 7 (April 30, 2019): 2878–87. https://doi.org/10.1172/JCI127195.

Full Text

Pages